ADmit Therapeutics — Seed (estimated) · €785K

A €785K equity round led by Ship2B's Equity4Good vehicle, which is backed by the European Investment Fund. Part of it was raised through the Capital Cell crowdfunding platform, and a sector investor who was not named also took part. It was announced together with a €3.4M EIC Accelerator award, which brought total new funding to €4.2M. Earlier, in May 2020, the company received a separate $497,652 grant from the ADDF Diagnostics Accelerator.